BRIEF published on 11/27/2025 at 07:05, 9 months 15 days ago U-blox Appoints Matthias Poppel as Chief Growth Officer Semiconductor Industry U-blox Leadership Chief Growth Officer Matthias Poppel
BRIEF published on 11/27/2025 at 07:05, 9 months 15 days ago U-blox nomme Matthias Poppel au poste de directeur de la croissance U-blox Direction Industrie Des Semi-conducteurs Directeur De La Croissance Matthias Poppel
BRIEF published on 11/27/2025 at 02:10, 9 months 15 days ago Beyless Secures ASPICE CL2 Certification for Software Quality Automotive Industry South Korea Global OEMs ASPICE CL2 Certification Software Quality
BRIEF published on 11/27/2025 at 02:10, 9 months 15 days ago Beyless obtient la certification ASPICE CL2 pour la qualité de ses logiciels. Industrie Automobile Corée Du Sud Certification ASPICE CL2 Qualité Logicielle Équipementiers Mondiaux
BRIEF published on 11/27/2025 at 02:05, 9 months 15 days ago GLG Life Tech Corporation Announces Q3 2025 Financial Results Revenue Decline GLG Life Tech Q3 Financial Results Market Competition Stevia Market
BRIEF published on 11/27/2025 at 02:05, 9 months 15 days ago GLG Life Tech Corporation annonce ses résultats financiers du troisième trimestre 2025 Baisse Des Revenus GLG Life Tech Résultats Financiers Du Troisième Trimestre Concurrence Sur Le Marché Marché De La Stévia
BRIEF published on 11/27/2025 at 00:20, 9 months 15 days ago Transgene : Reprise de la Cotation sur Euronext Paris Euronext Paris Biotechnologie Augmentation De Capital Cotation Transgene
BRIEF published on 11/27/2025 at 00:20, 9 months 15 days ago Transgene: Resumption of Trading on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Quoting
BRIEF published on 11/26/2025 at 23:37, 9 months 15 days ago Transgene Raises €105 Million for Cancer Vaccine Development Biotechnology Fundraising Cancer Vaccines Transgene Myvac® Platform
BRIEF published on 11/26/2025 at 23:37, 9 months 15 days ago Transgene lève 105 millions d'euros pour le développement d'un vaccin contre le cancer Biotechnologie Collecte De Fonds Vaccins Contre Le Cancer Transgene Plateforme Myvac®
Published on 09/12/2026 at 02:35, 10 hours 2 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 13 hours 37 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 14 hours 32 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 15 hours 12 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 19 hours 37 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 5 hours 7 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 14 hours 22 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 14 hours 27 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 16 hours 52 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 18 hours 22 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 5 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 5 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 17 hours ago Availability of the 2026 Interim Financial Report
